Vera Therapeutics Inc (VERA)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current VERA market cap is 1.9B. The company's latest EPS is USD -1.7548 and P/E is -19.75.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31.26M | -21.97M | -21.76M | -27.03M | -31.11M |
| Net Income | -30.07M | -20.16M | -20.1M | -25.66M | -28.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.96M | -52.24M | -34.4M | -90.9M | -102.01M |
| Net Income | -11.85M | -53.41M | -32.61M | -89.06M | -95.99M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 209.6M | 195.18M | 175.62M | 175.55M | 419.36M |
| Total Liabilities | 51.9M | 54.66M | 51.91M | 73.86M | 65.81M |
| Total Equity | 157.71M | 140.52M | 123.71M | 101.69M | 353.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 5.38M | 54.55M | 83.75M | 131.44M | 175.55M |
| Total Liabilities | 1.83M | 4.33M | 14.16M | 54.53M | 73.86M |
| Total Equity | -36.55M | -89.35M | 69.59M | 76.91M | 101.69M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -26.29M | -44.06M | -67.04M | -92.18M | -33.83M |
| Investing | 12.23M | -74.22M | -57.99M | -39.43M | -219.29M |
| Financing | 107.98M | 108.42M | 108.71M | 133.54M | 276.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -10.29M | -34.81M | -23.71M | -67.6M | -92.18M |
| Investing | -125k | -42k | -4.2M | -70.55M | -39.43M |
| Financing | -137k | 85.29M | 53.88M | 101.93M | 133.54M |
| Market Cap | 1.9B |
| Price to Earnings Ratio | -19.75 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 41.49 |
| Price to Book Ratio | 18.64 |
| Dividend Yield | - |
| Shares Outstanding | 54.7M |
| Average Volume (1 week) | 778.4k |
| Average Volume (1 Month) | 610.59k |
| 52 Week Change | 107.36% |
| 52 Week High | 50.78 |
| 52 Week Low | 9.24 |
| Spread (Intraday) | 26.13 (65.33%) |
| Company Name | Vera Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://veratx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
